Scott Moore explores China’s trajectory in the global biotechnology sector. Whilst America has been the dominant world wide participant in acquiring and commercializing biotechnology for decades, China is set to become a number one player in biotechnology and is particularly investing heavily in the sector. Moore argues that, although the U.S. is